Concepedia

Jakub Netolický

JN

Statistics

Publications

3

Citations

47

H-Index

3

Active since

2020

Affiliations

Charles University(Current)

Czech Academy of Sciences, Institute of Experimental Medicine

University Hospital Hradec Králové

University of Defence

Jakub Netolický is an author at Charles University specializing in medicine, medicinal chemistry, and drug discovery.

ORCID

Top concepts

Publications per year

2020–2024

3

Publications

3

The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors

Kristýna Skřenková, Jae-man Song, Štěpán Kortus et al. · Scientific Reports · 2020 · 20 citations · Full text

The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors

Marharyta Kolcheva, Marek Ladislav, Jakub Netolický et al. · Neuropharmacology · 2022 · 16 citations · Full text

Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition

Anna Misiachna, Barbora Svobodová, Jakub Netolický et al. · European Journal of Medicinal Chemistry · 2024 · 11 citations · Full text

, , +17

1–3 of 3